These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1366088)

  • 21. [Molecular biology approach to development of gene-specific pharmacological preparations].
    Seredenin SB; Vakhitova IuV; Vakhitov VA
    Eksp Klin Farmakol; 2001; 64(3):3-12. PubMed ID: 11558435
    [No Abstract]   [Full Text] [Related]  

  • 22. RNA interference: the silent treatment.
    Clayton J
    Nature; 2004 Sep; 431(7008):599-605. PubMed ID: 15457267
    [No Abstract]   [Full Text] [Related]  

  • 23. Oligonucleotide, antibody and peptide therapeutics--from design to the clinic.
    Goodchild J
    Curr Opin Mol Ther; 2004 Apr; 6(2):119. PubMed ID: 15195921
    [No Abstract]   [Full Text] [Related]  

  • 24. QC in antisense oligo synthesis.
    Agris PF; Smith S; Fu C; Simkins SG
    Nat Biotechnol; 2002 Sep; 20(9):871-2. PubMed ID: 12205500
    [No Abstract]   [Full Text] [Related]  

  • 25. Current status of gene therapy for muscle diseases.
    Thirion C; Lochmüller H
    Drug News Perspect; 2007; 20(6):357-63. PubMed ID: 17925889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical application and significance of drug delivery systems. Targeting SOD by gene and protein engineering].
    Inoue M; Ando Y; Watanabe N
    Nihon Rinsho; 1989 Jun; 47(6):1340-6. PubMed ID: 2769994
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antisense technology: overview and bridged nucleic acid analogs].
    Imanishi T
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1616-24. PubMed ID: 12931621
    [No Abstract]   [Full Text] [Related]  

  • 29. Antisense-mediated redirection of mRNA splicing.
    Vacek M; Sazani P; Kole R
    Cell Mol Life Sci; 2003 May; 60(5):825-33. PubMed ID: 12827272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
    Branch AD
    Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioprocess-centered molecular design (BMD) for the efficient production of an interfacially active peptide.
    Morreale G; Lee EG; Jones DB; Middelberg AP
    Biotechnol Bioeng; 2004 Sep; 87(7):912-23. PubMed ID: 15334418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
    Delihas N; Rokita SE; Zheng P
    Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proof of mechanism of antisense drugs.
    Crooke ST
    Antisense Nucleic Acid Drug Dev; 1996; 6(2):145-7. PubMed ID: 8843330
    [No Abstract]   [Full Text] [Related]  

  • 35. [Perspectives on practical use of biotechnologic advances, molecular biology and cellular engineering in clinical hematology].
    Ratajczak MZ
    Pol Arch Med Wewn; 1994 Nov; 92(5):373-9. PubMed ID: 7885984
    [No Abstract]   [Full Text] [Related]  

  • 36. The molecular medicine series.
    Stoeckle M
    N Engl J Med; 1995 May; 332(18):1240. PubMed ID: 7700330
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibody engineering for advanced molecular recognition].
    Kobayashi N; Goto J
    Yakugaku Zasshi; 2007 Jan; 127(1):41-2. PubMed ID: 17202783
    [No Abstract]   [Full Text] [Related]  

  • 38. Engineering and design.
    Curr Opin Struct Biol; 1996 Aug; 6(4):572-81. PubMed ID: 8846202
    [No Abstract]   [Full Text] [Related]  

  • 39. Engineering and design.
    Curr Opin Struct Biol; 1997 Aug; 7(4):581-91. PubMed ID: 9266182
    [No Abstract]   [Full Text] [Related]  

  • 40. [Gene technology and current possibilities for pharmacological intervention].
    Pelkonen O
    Duodecim; 1992; 108(15):1299-300. PubMed ID: 1366088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.